金乐;吉民;

• 1:东南大学生物科学与医学工程学院

摘要(Abstract)：

电子计算机断层扫描(computed tomography,CT)成像是重要的临床医学诊断手段,而造影剂是其中的重要组成部分。提高造影剂的靶向性,有利于对疾病进行早期诊断是造影剂研究发展的一大趋势。本文对靶向CT造影剂的研究进展作一概要介绍。

关键词(KeyWords)： CT成像;造影剂;靶向;研究进展

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金(81671745);; 江苏省科学技术计划支持产业项目(BE2013840);; 苏州科学和技术发展规划(ZXY201412)

作者(Authors): 金乐;吉民;

DOI: 10.16088/j.issn.1001-6600.2017.03.010

参考文献(References)：

• [1]刘玉,陶晓峰.CT成像造影剂的研究进展[J].上海医药,2014,7(10):265-267.
• [2]苟量,王绪本,曹辉.X射线成像技术的发展现状和趋势[J].成都理工学院学报,2002,29(2):227-231.
• [3]范建中,杨金文.用X射线实验仪研究X射线的衰减规律[J].太原师范学院学报(自然科学版),2011,10(3):95-98.
• [4]李惠芝,李铁福,刘晶莹,等.CT用硫酸钡造影剂的制备[J].沈阳药科大学学报,2001,18(5):13-15.
• [5]张婷婷,王哲,徐静静,等.新型碘造影剂STL-02的合成[J].中国新药杂志,2012,21(24):2948-2950.
• [6]BRADAMANTE S,VITTADINI G.Non-ionic X-ray contrast agents:detection of ambient temperature isomers of congested hexasubstituted benzenes with multipositional hindered rotations[J].Magnetic Resonance in Chemistry,1987,25(4):283-292.
• [7]CHRISTIANSEN C.X-ray contrast media-an overview[J].Toxicology,2005,209(2):185-187.
• [8]HOEY G B,SMITH K R.Radiocontrast agents[M].Berlin:Springer Book Archive,1984:23-125.
• [9]KRAUSE W,NIEHUES D.Biochemical characterization of X-ray contrastmedia[J].Investigative Radiology,1996,31(1):30-42.
• [10]ARUNACHALAM T,FAN H,PILLAIK M R,et al.Heterocyclic nonionic X-ray contrast agents.IV:the synthesis of dihydro-2(3H)-furanylidenamino,5-oxo-1-pyrrolidinyl,and 5-oxo-4-morpholinyl derivatives by an intramolecular iodocyclization approach[J].Journal of Organic Chemistry,1995,60(14):4428-4438.
• [11]杨天师,王海燕,韩大雄.新型非离子型单体碘造影剂的合成[J].中国现代应用药学,2013,30(8):843-847.
• [12]HAINFELD J F,SLATKIN D N,FOCELLA T M,et al.Gold nanoparticles:a new X-ray contrast agent[J].Br J Radiol,2006,79:248-253.
• [13]魏若林.血管造影的历史[J].实用放射学杂志,1987,2:36.
• [14]GAVANT M L,ELLIS J V,KLESGES L M,et al.Diagnostic efficacy of excretory urography with low-dose,nonionic contrast media[J].Radiology,1992,182(3):657-660.
• [15]GHAREKHANLOO F,TORABIAN S.Comparison of allergic adverse effects and contrast enhancement between iodixanol and iopromide[J].Iran J Radiol,2012,9(2):63-66.
• [16]张建英,裘华兴,蒋宁,等.非离子型造影剂与传统造影剂在子宫输卵管造影中的诊断效果及适用性研究[J].中国医学影像技术,2003,19(5):568-570.
• [17]罗世能,谢敏浩.非离子型X-CT造影剂碘海醇的合成[J].中国医药工业杂志,1995,26(10):433-435.
• [18]PARKESH R,GOWIN W,LEE T C,et al.Synthesis and evaluation of potential CT(computer tomography)contrast agents for bone structure and microdamage analysis[J].Organic and Biomolecular Chemistry,2006,4(19):3611-3617.
• [19]JOSHI N S,BANSAL P N,STEWART R C,et al.Effect of contrast agent charge on visualization of articular cartilage using computed tomography:exploiting electrostatic interactions for improved sensitivity[J].Journal of the American Chemical Society,2009,131(37):13234-13235.
• [20]朱陵君,李晓林,李茹恬,等.智能型靶向纳米给药系统提高肿瘤治疗效果的新途径[J].临床肿瘤学杂志,2009,14(4):373-376.
• [21]HUBBELL J H,SELTZER S M.Tables of X-ray mass attenuation coefficients and mass energy-absorption coefficients 1keV to 20 MeV for elements Z=1to 92and 48additional substances of dosimetric interest[R].Gaithersburg,MD:National Inst.of Standards and Technology-PL,1995.
• [22]范旭,郭志睿,曹敏,等.基于金纳米颗粒的CT造影剂[J].CT理论与应用研究,2009,18(4):15-25.
• [23]林苏娜,林华庆.纳米粒作为抗肿瘤药物载体的研究进展[J].中国肿瘤临床,2013,40(6):363-365.
• [24]李大伟.纳米给药系统在肿瘤靶向治疗中的应用[J].食品与药品,2010,12(9):357.
• [25]MAEDA H,WU J,SAWA T,et al.Tumor vascular permeability and the EPR effect in macromolecular therapeutics:a review[J].Journal of Controlled Release,2000,65(1):271-284.
• [26]MAEDA H,NAKAMURA H,FANG J.The EPR effect for macromolecular drug delivery to solid tumors:Improvement of tumor uptake,lowering of systemic toxicity,and distinct tumor imaging in vivo[J].Advanced Drug Delivery Reviews,2013,65(1):71-79.
• [27]DREIFUSS T,BETZER O,SHILO M,et al.A challenge for theranostics:is the optimal particle for therapy also optimal for diagnostics?[J].Nanoscale,2015,7(37):15175-15184.
• [28]DU Y,XING M,LI Z,et al.PEGylated Gd(OH)3 nanorods as metabolizable contrast agents for computed tomography imaging[J].New Journal of Chemistry,2015,39(11):8999-9005.
• [29]BANGHAM A D,STANDISH M M,WATKINS J C.Diffusion of univalent ions across the lamellae of swollen phospholipids[J].Journal of Molecular Biology,1965,13(1):238-252.
• [30]赵学良.脂质体[J].国外医学:皮肤性病学分册,1997,23(6):355-358.
• [31]AKBARZADEH A,REZAEI-SADABADY R,DAVARAN S,et al.Liposome:classification,preparation,and applications[J].Nanoscale Research Letters,2013,8(1):1.
• [32]CHEN C,HAN D,CAI C,et al.An overview of liposome lyophilization and its future potential[J].Journal of Controlled Release,2010,142(3):299-311.
• [33]于洋,陈涛,卢婷利.碘造影剂脂质体的研究进展[J].中国医学影像技术,2008,6:63.
• [34]杨硕晔,王杏林,杨志强.洛莫司汀-碘海醇复方脂质体的制备及包封率测定[J].中国药房,2014,25(1):48-51.
• [35]BHAVANE R,BADEA C,GHAGHADA K B,et al.Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent[J].Circulation:Cardiovascular Imaging,2013,6(2):285-294.
• [36]ELROD D B,PARTHA R,DANILA D,et al.An iodinated liposomal computed tomographic contrast agent prepared from a diiodophosphatidylcholine lipid[J].Nanomedicine:Nanotechnology,Biology and Medicine,2009,5(1):42-45.